SCHEMBL6174749

SCHEMBL6174749

CC1(Cc2ccncc2-c2ccc(F)cc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.38
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
CTSD P07339 4/20 0.33
BACE1 P56817 4/20 0.33
BACE2 Q9Y5Z0 4/20 0.33
MMP2 P08253 3/20 0.33
MMP1 P03956 2/20 0.33
MMP3 P08254 2/20 0.33
MMP9 P14780 2/20 0.33
REN P00797 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172098 0.92 AR (0.37) ARCYP3A4GAACYP2C9CYP2C19
SCHEMBL6170776 0.85 DGAT2 (0.38) ARALDH1A1CTSDBACE1BACE2
SCHEMBL6172334 0.85 IGF1R (0.40) ARTSHRKMT2AALDH1A1LMNA
SCHEMBL6175571 0.84 ALDH1A1 (0.38) ARTSHRKMT2ACYP3A4GAA
SCHEMBL6173695 0.84 ITGAL (0.40) ARKMT2ACYP3A4GAACYP2C9
SCHEMBL6172435 0.83 POLB (0.38) ARCYP3A4GAACYP2C9CYP2C19
SCHEMBL6173183 0.82 CYP3A4 (0.39) ARCYP3A4GAACYP2C9CYP2C19
SCHEMBL6277096 0.82 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6170496 0.81 CYP3A4 (0.40) ARCYP3A4GAACYP2C9CYP2C19
SCHEMBL6176402 0.81 SLC6A4 (0.36) ARCYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed